NASDAQ:ADXN

Addex Therapeutics Ltd Earning Date

USA |NASDAQ |USD |ADR

ADXN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Dec 31, 2021 (est) Sep 30, 2021 - $-0.91 $-0.09
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Dec 31, 2021 (est) Sep 30, 2021 - $992.60K $27.26K

Addex Therapeutics Ltd's next estimated earnings date (based on same quarter last year's date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.

ADXN Earnings Date & History Chart

ADXN Earnings Date & Revenue History

ADXN Earnings History

|
Show More
Show More

ADXN Revenue History

|
Show More
Show More

Addex Therapeutics Ltd Next Earnings Date & Report

ADXN Aug 2021 (FQ) Earnings Date & Report Preview

ADXN's next estimated earnings date (based on same quarter last year's report date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.

Addex Therapeutics Ltd Previous Earnings Dates & Reports

ADXN Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Addex Therapeutics Ltd's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

ADXN's earnings per share (EPS) was $-0.91.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 509.88%, and lower than the same period a year before (Jun 2020) by 573.22%.

Revenues were $992.60K, up by 17.57% from the previous quarter , and up by 6.46% from the same period last year.

The company reported a net income of $-4.69M.

Free cash flow for the quarter was $-6.45M , compared to $-2.77M last quarter and $-6.17M a year before.

ADXN ended the quarter with $420.16K in total debt, a decrease of -14.22% compared to the previous quarter.

ADXN Previous Earnings Date & Report Recap: Dec 2020 (FY)

Addex Therapeutics Ltd's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

ADXN's earnings per share (EPS) was $-0.43.

Revenues were $3.61M, up by 30.77% from previous year's revenue.

The company reported a net income of $-12.86M.

Addex Therapeutics Ltd reported a free cash flow of $-12.24M for its fiscal year, compared to $-9.51M a year ago.

The company ended the fiscal year with $567.40K in total debt. lala